Bioelectronic Medicine Company Boomerang Medical Raises $15M In Series A Financing
Nov 01, 2022•almost 3 years ago
Amount Raised
$15 Million
Round Type
series a
Description
Boomerang Medical, a women-led bioelectronic medicine company, today announced the closing of a $15 million Series A financing led by existing investor Arboretum Ventures and new investor Hatteras Venture Partners. This round brings Boomerang’s total funding to $18 million to date. Boomerang will use the proceeds from the financing to advance clinical studies on neuromodulation for the treatment of autoimmune diseases, with an initial focus on Inflammatory Bowel Disease (IBD).
Funding Insights
Based on industry dataTech investment trends
83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech